Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19).
Helio Silva SaderRodrigo E MendesLeonard R DuncanCecilia Godoy CarvalhaesMariana CastanheiraPublished in: The Journal of antimicrobial chemotherapy (2022)
Cefepime/zidebactam demonstrated potent in vitro activity against a large worldwide collection of contemporary clinical isolates of Gram-negative bacteria.